How to Develop a National Formulary Based on the WHO Model Formulary - A Practical Guide
(2004; 45 pages) View the PDF document
Table of Contents
View the documentAbbreviations
Open this folder and view contents1 INTRODUCTION
Open this folder and view contents2 OVERVIEW OF THE NATIONAL FORMULARY PROCESS
Open this folder and view contents3 DEVELOPING THE PRELIMINARY INFORMATION SECTION
Open this folder and view contents4 DEVELOPMENT OF THERAPEUTIC INFORMATION AND MONOGRAPHS USING THE WHO MODEL FORMULARY
Open this folder and view contents5 ADDITIONAL SOURCES OF INFORMATION
Open this folder and view contents6 DEVELOPING SPECIFIC INFORMATION SECTIONS
Open this folder and view contents7 PRODUCTION, DISTRIBUTION AND IMPLEMENTATION
Close this folder8 EVALUATION
View the documentEvaluation of the NF within the framework of existing monitoring and evaluation activities
View the documentHow to design the evaluation
Close this folderWhat to evaluate
View the documentPolicy, legal framework and management support
View the documentSelection
View the documentProcurement
View the documentDistribution of formulary
View the documentRational use
Open this folder and view contents9 REVIEW AND UPDATE
View the documentREFERENCES
 

Rational use

Indicators

1. Percentage of medicines prescribed from NF as per NF instruction for selected indicator diseases: for example, treatment of uncomplicated malaria in adults or treatment of peptic ulcer.

It is necessary to identify the recommended dosage schedule from the NF and review prescriptions and/or medication charts for the relevant disease. This can be difficult when diagnosis and prescription information are recorded in separate documents.

Calculate:

2. Is the NF included in the list of recommended textbooks and used for training of health professionals in the country? Yes/No


The results of the evaluation should be summarized in a short report together with any recommendations for improvements. This report should be circulated to members of the NFC and others involved in production and implementation of the NF, preferably before starting the review process for the next edition.

 

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: August 29, 2014